JMP chat | PGEN Message Board Posts


PGEN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  55094 of 55494  at  12/6/2023 7:46:32 PM  by

Redwood1205


 In response to msg 55093 by  UnclePhil
view thread

Re: JMP chat

It was interesting that Helen said that efficacy on 3006 was sufficient to obviate the need to go to higher dose levels. That is quite a statement particularly since 3007 starts at the highest 3006 dose and goes to 30 to 40 times that level. 
I would guess delays in CART data are related to slower ramp of new sites for budget reasons. There are also other explanations which could be both positive and negative. For example, they are now re-dosing which if successful would delay reaching endpoints.
If everyone died in three months, the results are reached much quicker. 
The catalysts are likely to be the announcement of partnerships which could come at any time. I find it interesting that there were no insider purchases right after the Q3 release.  


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...